Global Whole Genome and Exome Sequencing Market Research Report 2024(Status and Outlook)
Report Overview:
Whole Genome Sequencing sequences the complete DNA of an organism. In the case of a human this corresponds to about three billion base pairs of DNA. Whole genome sequencing entails sequencing all coding (exons) and noncoding (intron) nuclear DNA as well as mitochondrial DNA. This allows researchers to generate large quantities of data, which can then be analyzed.The exome makes up only 1.5% of the whole human genome, however ALL protein coding genes are found in the exome. Since most genetic disorders are correlated with mutations in protein coding genes, most physicians and scientists who use sequencing technologies for diagnostic purposes start with an analysis of the exome.
The Global Whole Genome and Exome Sequencing Market Size was estimated at USD 327.07 million in 2023 and is projected to reach USD 625.11 million by 2029, exhibiting a CAGR of 11.40% during the forecast period.
This report provides a deep insight into the global Whole Genome and Exome Sequencing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Whole Genome and Exome Sequencing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Whole Genome and Exome Sequencing market in any manner.
Global Whole Genome and Exome Sequencing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eurofins Scientific SE
Agilent Technologies, Inc
Beijing Genomics Institute (BGI)
Hoffmann-La Roche Ltd
Bio-Rad Laboratories, Inc
GENEWIZ, Inc
Illumina, Inc
Laboratory Corporation of America Holdings
Novogene Corporation
Oxford Nanopore Technologies, Inc
Pacific Biosciences of California, Inc
QIAGEN N.V
Thermo Fisher Scientific Inc
Cytiva
Market Segmentation (by Type)
By Product
Kits
Instruments
By Workflow
Whole Genome Sequencing (WGS)
Whole Exome Sequencing (WES)
Market Segmentation (by Application)
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Diagnostic Labs
Research Centres, Academia and Government Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Whole Genome and Exome Sequencing Market
Overview of the regional outlook of the Whole Genome and Exome Sequencing Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Whole Genome and Exome Sequencing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Whole Genome and Exome Sequencing
- 1.2 Key Market Segments
- 1.2.1 Whole Genome and Exome Sequencing Segment by Type
- 1.2.2 Whole Genome and Exome Sequencing Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Whole Genome and Exome Sequencing Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Whole Genome and Exome Sequencing Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Whole Genome and Exome Sequencing Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Whole Genome and Exome Sequencing Market Competitive Landscape
- 3.1 Global Whole Genome and Exome Sequencing Sales by Manufacturers (2019-2024)
- 3.2 Global Whole Genome and Exome Sequencing Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Whole Genome and Exome Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Whole Genome and Exome Sequencing Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Whole Genome and Exome Sequencing Sales Sites, Area Served, Product Type
- 3.6 Whole Genome and Exome Sequencing Market Competitive Situation and Trends
- 3.6.1 Whole Genome and Exome Sequencing Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Whole Genome and Exome Sequencing Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Whole Genome and Exome Sequencing Industry Chain Analysis
- 4.1 Whole Genome and Exome Sequencing Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Whole Genome and Exome Sequencing Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Whole Genome and Exome Sequencing Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Whole Genome and Exome Sequencing Sales Market Share by Type (2019-2024)
- 6.3 Global Whole Genome and Exome Sequencing Market Size Market Share by Type (2019-2024)
- 6.4 Global Whole Genome and Exome Sequencing Price by Type (2019-2024)
- 7 Whole Genome and Exome Sequencing Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Whole Genome and Exome Sequencing Market Sales by Application (2019-2024)
- 7.3 Global Whole Genome and Exome Sequencing Market Size (M USD) by Application (2019-2024)
- 7.4 Global Whole Genome and Exome Sequencing Sales Growth Rate by Application (2019-2024)
- 8 Whole Genome and Exome Sequencing Market Segmentation by Region
- 8.1 Global Whole Genome and Exome Sequencing Sales by Region
- 8.1.1 Global Whole Genome and Exome Sequencing Sales by Region
- 8.1.2 Global Whole Genome and Exome Sequencing Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Whole Genome and Exome Sequencing Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Whole Genome and Exome Sequencing Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Whole Genome and Exome Sequencing Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Whole Genome and Exome Sequencing Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Whole Genome and Exome Sequencing Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Eurofins Scientific SE
- 9.1.1 Eurofins Scientific SE Whole Genome and Exome Sequencing Basic Information
- 9.1.2 Eurofins Scientific SE Whole Genome and Exome Sequencing Product Overview
- 9.1.3 Eurofins Scientific SE Whole Genome and Exome Sequencing Product Market Performance
- 9.1.4 Eurofins Scientific SE Business Overview
- 9.1.5 Eurofins Scientific SE Whole Genome and Exome Sequencing SWOT Analysis
- 9.1.6 Eurofins Scientific SE Recent Developments
- 9.2 Agilent Technologies, Inc
- 9.2.1 Agilent Technologies, Inc Whole Genome and Exome Sequencing Basic Information
- 9.2.2 Agilent Technologies, Inc Whole Genome and Exome Sequencing Product Overview
- 9.2.3 Agilent Technologies, Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.2.4 Agilent Technologies, Inc Business Overview
- 9.2.5 Agilent Technologies, Inc Whole Genome and Exome Sequencing SWOT Analysis
- 9.2.6 Agilent Technologies, Inc Recent Developments
- 9.3 Beijing Genomics Institute (BGI)
- 9.3.1 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Basic Information
- 9.3.2 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product Overview
- 9.3.3 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing Product Market Performance
- 9.3.4 Beijing Genomics Institute (BGI) Whole Genome and Exome Sequencing SWOT Analysis
- 9.3.5 Beijing Genomics Institute (BGI) Business Overview
- 9.3.6 Beijing Genomics Institute (BGI) Recent Developments
- 9.4 Hoffmann-La Roche Ltd
- 9.4.1 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Basic Information
- 9.4.2 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product Overview
- 9.4.3 Hoffmann-La Roche Ltd Whole Genome and Exome Sequencing Product Market Performance
- 9.4.4 Hoffmann-La Roche Ltd Business Overview
- 9.4.5 Hoffmann-La Roche Ltd Recent Developments
- 9.5 Bio-Rad Laboratories, Inc
- 9.5.1 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Basic Information
- 9.5.2 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product Overview
- 9.5.3 Bio-Rad Laboratories, Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.5.4 Bio-Rad Laboratories, Inc Business Overview
- 9.5.5 Bio-Rad Laboratories, Inc Recent Developments
- 9.6 GENEWIZ, Inc
- 9.6.1 GENEWIZ, Inc Whole Genome and Exome Sequencing Basic Information
- 9.6.2 GENEWIZ, Inc Whole Genome and Exome Sequencing Product Overview
- 9.6.3 GENEWIZ, Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.6.4 GENEWIZ, Inc Business Overview
- 9.6.5 GENEWIZ, Inc Recent Developments
- 9.7 Illumina, Inc
- 9.7.1 Illumina, Inc Whole Genome and Exome Sequencing Basic Information
- 9.7.2 Illumina, Inc Whole Genome and Exome Sequencing Product Overview
- 9.7.3 Illumina, Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.7.4 Illumina, Inc Business Overview
- 9.7.5 Illumina, Inc Recent Developments
- 9.8 Laboratory Corporation of America Holdings
- 9.8.1 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Basic Information
- 9.8.2 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product Overview
- 9.8.3 Laboratory Corporation of America Holdings Whole Genome and Exome Sequencing Product Market Performance
- 9.8.4 Laboratory Corporation of America Holdings Business Overview
- 9.8.5 Laboratory Corporation of America Holdings Recent Developments
- 9.9 Novogene Corporation
- 9.9.1 Novogene Corporation Whole Genome and Exome Sequencing Basic Information
- 9.9.2 Novogene Corporation Whole Genome and Exome Sequencing Product Overview
- 9.9.3 Novogene Corporation Whole Genome and Exome Sequencing Product Market Performance
- 9.9.4 Novogene Corporation Business Overview
- 9.9.5 Novogene Corporation Recent Developments
- 9.10 Oxford Nanopore Technologies, Inc
- 9.10.1 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Basic Information
- 9.10.2 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product Overview
- 9.10.3 Oxford Nanopore Technologies, Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.10.4 Oxford Nanopore Technologies, Inc Business Overview
- 9.10.5 Oxford Nanopore Technologies, Inc Recent Developments
- 9.11 Pacific Biosciences of California, Inc
- 9.11.1 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Basic Information
- 9.11.2 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product Overview
- 9.11.3 Pacific Biosciences of California, Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.11.4 Pacific Biosciences of California, Inc Business Overview
- 9.11.5 Pacific Biosciences of California, Inc Recent Developments
- 9.12 QIAGEN N.V
- 9.12.1 QIAGEN N.V Whole Genome and Exome Sequencing Basic Information
- 9.12.2 QIAGEN N.V Whole Genome and Exome Sequencing Product Overview
- 9.12.3 QIAGEN N.V Whole Genome and Exome Sequencing Product Market Performance
- 9.12.4 QIAGEN N.V Business Overview
- 9.12.5 QIAGEN N.V Recent Developments
- 9.13 Thermo Fisher Scientific Inc
- 9.13.1 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Basic Information
- 9.13.2 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product Overview
- 9.13.3 Thermo Fisher Scientific Inc Whole Genome and Exome Sequencing Product Market Performance
- 9.13.4 Thermo Fisher Scientific Inc Business Overview
- 9.13.5 Thermo Fisher Scientific Inc Recent Developments
- 9.14 Cytiva
- 9.14.1 Cytiva Whole Genome and Exome Sequencing Basic Information
- 9.14.2 Cytiva Whole Genome and Exome Sequencing Product Overview
- 9.14.3 Cytiva Whole Genome and Exome Sequencing Product Market Performance
- 9.14.4 Cytiva Business Overview
- 9.14.5 Cytiva Recent Developments
- 10 Whole Genome and Exome Sequencing Market Forecast by Region
- 10.1 Global Whole Genome and Exome Sequencing Market Size Forecast
- 10.2 Global Whole Genome and Exome Sequencing Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Whole Genome and Exome Sequencing Market Size Forecast by Country
- 10.2.3 Asia Pacific Whole Genome and Exome Sequencing Market Size Forecast by Region
- 10.2.4 South America Whole Genome and Exome Sequencing Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Whole Genome and Exome Sequencing by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Whole Genome and Exome Sequencing Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Whole Genome and Exome Sequencing by Type (2025-2030)
- 11.1.2 Global Whole Genome and Exome Sequencing Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Whole Genome and Exome Sequencing by Type (2025-2030)
- 11.2 Global Whole Genome and Exome Sequencing Market Forecast by Application (2025-2030)
- 11.2.1 Global Whole Genome and Exome Sequencing Sales (K Units) Forecast by Application
- 11.2.2 Global Whole Genome and Exome Sequencing Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook